Clinical Trial

Safety and Effectiveness Study of OR3O™ Dual Mobility System in THA

Study acronym: OR3O
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to assess the safety and effectiveness of the OR3O™ Dual Mobility System. The study will evaluate the outcome of the Total Hip Arthroplasty using the OR3O™ Dual Mobility System over a ten year period. Survivorship of THA will be assessed up to ten years.
Protocol Amendment History 19 amendments
This ClinicalTrials.gov record has been amended 19 times since 2020-03-25; most recent amendment 2026-06-30.
Status change: Recruiting → Active, Not Recruiting 2024-11-07
Status change: Not Yet Recruiting → Recruiting 2021-03-09
Trial Details
NCT Number NCT04325022
Lead Sponsor Smith & Nephew, Inc.
Conditions Advanced Degeneration of the Hip Joint, Revision of the Hip Joint
Enrollment 177 participants
Start Date 2020-07-27
Primary Completion 2026-02-23 (estimated)
Study Completion 2035-01-31 (estimated)
Updated on ClinicalTrials.gov 2026-07-02